Charles River Laboratories International Depreciation & Amortization 2011-2026 | CRL

Annual Depreciation & Amortization Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
403 M	362 M	314 M	304 M	266 M	235 M	198 M	162 M	131 M	127 M	94.9 M	96.4 M	96.6 M	81.3 M	85.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
403 M	81.3 M	197 M

Quarterly Depreciation & Amortization Charles River Laboratories International

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
85.2 M	120 M	120 M	-	88.2 M	86.1 M	85.4 M	-	78.9 M	77.7 M	77.1 M	-	74.6 M	76.4 M	75.3 M	-	68.7 M	68.1 M	61.5 M	-	59.6 M	57.2 M	57.3 M	-	51.8 M	49.1 M	45.4 M	-	43.6 M	43.4 M	33.2 M	-	33.5 M	31.8 M	32.4 M	-	34.1 M	32.4 M	24.7 M	-	23.8 M	23.1 M	22.4 M	-	26.1 M	24.3 M	20 M	-	67.3 M	40.4 M	20 M	-	60.6 M	40.1 M	20 M	-	64.2 M	43.1 M	21.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
120 M	20 M	53.1 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Agilent Technologies A	321 M	$ 110.24	-2.86 %	$ 33.5 B	USA
Waters Corporation WAT	88.1 M	$ 289.16	-3.79 %	$ 17.2 B	USA
Exagen XGN	2.1 M	$ 2.68	-3.94 %	$ 57.8 M	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	47.8 M	$ 16.36	-11.57 %	$ 176 M	China
Sotera Health Company SHC	94.9 M	$ 13.13	-3.03 %	$ 3.73 B	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
ICON Public Limited Company ICLR	488 M	$ 102.08	-0.97 %	$ 8.42 B	Irlanda
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
BioNano Genomics BNGO	9.53 M	$ 1.16	0.87 %	$ 6.32 M	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	264 K	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	252 M	$ 62.25	-5.81 %	$ 24.3 B	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Castle Biosciences CSTL	16 M	$ 23.53	-4.74 %	$ 654 M	USA
Quest Diagnostics Incorporated DGX	570 M	$ 195.51	-1.33 %	$ 21.7 B	USA
Organovo Holdings ONVO	266 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	175 K	-	-16.95 %	$ 1.54 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
PerkinElmer PKI	405 M	-	-0.91 %	$ 14.7 B	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA
Interpace Biosciences IDXG	300 K	$ 1.68	-2.89 %	$ 7.37 M	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	119 M	$ 8.7	-4.92 %	$ 1.89 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	681 M	$ 264.2	-1.56 %	$ 22 B	USA
Psychemedics Corporation PMD	1.7 M	-	-1.84 %	$ 15.3 M	USA
Precipio PRPO	1.22 M	$ 25.97	-4.52 %	$ 33.7 M	USA
CareDx, Inc CDNA	15 M	$ 16.78	-3.95 %	$ 894 M	USA
Quotient Limited QTNT	8.8 M	-	-11.32 %	$ 1.1 M	Schweiz
Syneos Health SYNH	236 M	-	-	$ 4.46 B	USA
Renalytix AI plc RNLX	364 K	-	5.66 %	$ 22.7 M	Britain
VolitionRx Limited VNRX	1.11 M	$ 0.2	1.87 %	$ 19.2 M	Singapore
Bioventus BVS	47 M	$ 8.94	-3.46 %	$ 596 M	USA
Co-Diagnostics CODX	1.23 M	$ 4.4	101.83 %	$ 129 M	USA
Meridian Bioscience VIVO	16.5 M	-	-	$ 1.49 B	USA
Danaher Corporation DHR	750 M	$ 181.52	-3.27 %	$ 129 B	USA